Related Experiment Video

Updated: Jul 11, 2026

Evaluation of Caspase Activation to Assess Innate Immune Cell Death
10:23

Evaluation of Caspase Activation to Assess Innate Immune Cell Death

Published on: January 20, 2023

Screening of a novel octamer peptide, CNSCWSKD, that induces caspase-dependent cell death

Chiaki Kaga1, Mina Okochi, Mari Nakanishi

  • 1Department of Biotechnology, School of Engineering, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8603, Japan.

Biochemical and Biophysical Research Communications
|September 8, 2007
PubMed

Insights

Researchers identified a novel peptide, CNSCWSKD, that mimics Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) to selectively induce cancer cell death. This peptide shows potential for developing new cancer therapies by triggering apoptosis in tumor cells but sparing normal cells.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) selectively induces apoptosis in tumor cells.
  • Understanding TRAIL's mechanism is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To screen for cell death-inducing peptides derived from the TRAIL extracellular domain.
  • To identify and characterize novel TRAIL mimics for potential cancer treatment.

Main Methods:

  • Peptide array screening of TRAIL extracellular domain sequences.
  • Amino acid substitution for enhanced peptide activity.
  • Assays for apoptosis markers (DNA fragmentation, caspase activation, phosphatidylserine externalization, chromatin condensation).
  • Competition assays for binding to death receptors (DR4/DR5).

Main Results:

  • Identified CNSCWSKD peptide with >90% cell death induction in Jurkat cells.
  • CNSCWSKD demonstrated key apoptosis features and competed with TRAIL for DR4/DR5 binding.
  • Selective caspase-3 activation in tumor cells, but not normal fibroblasts, upon peptide treatment.

Conclusions:

  • The CNSCWSKD peptide acts as a TRAIL mimic, inducing apoptosis in cancer cells.
  • This peptide exhibits tumor cell selectivity, making it a promising candidate for cancer therapy development.

More Related Videos

Measuring Caspase Activity Using a Fluorometric Assay or Flow Cytometry05:29

Measuring Caspase Activity Using a Fluorometric Assay or Flow Cytometry

Published on: March 24, 2023

Identifying Caspases and their Motifs that Cleave Proteins During Influenza A Virus Infection08:16

Identifying Caspases and their Motifs that Cleave Proteins During Influenza A Virus Infection

Published on: July 21, 2022

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...